Delivering on the Promise of Purity

Delivering on the Promise of PurityTM

Facilities & Capabilities

Pfanstiehl maintains an 10-acre, 180,000 sq. ft., 16-building campus in Waukegan, Illinois USA that provides all the manufacturing, laboratory, warehousing, and administrative operations — all designed to assure the smooth flow of materials and information and to allow production under cGMP.

Active Pharmaceutical Ingredient Manufacturing

  • Potent API drug manufacturing facility scale:  1 to 70kg
  • Pilot manufacturing: up to 300 gallon reactors
  • Full scale (2,000 gallon), explosion-proof facility for processing with flammable solvents
  • Solvent recovery facility
API Kilo Lab Manufacturing Suite
  • Carlisle glove box synthesis isolator – Hastelloy C filter and contained tray drying
  • 100 liter glass reactor in Howorth full containment fume booth
  • 100 liter Hastelloy C hydrogenation reactor (50 psi)
  • Broad processing temperature range – (-)80ºC to (+)200ºC
  • Certified to handle compounds down to 0.10 ug/m³ – SafeBridge Category 4 capable
  • Kilo-scale non-cGMP custom synthesis
Pilot & Commercial Scale Manufacturing
  • Large Scale High Potency Manufacturing – Class 100,000 / SafeBridge Category 1-3 production facility
  • Multiple glass-lined 300 gallon reactor trains, with a total primary reactor capacity of 1,500 gallons
  • Flexible cGMP plant can produce up to ~100 Kg lots of potent / cytotoxic drugs
  • New 0.4 m² Hastelloy C Nutsche filter dryer with containment glove box isolator, as well as a multitude of portable Aurora filters (Hastelloy C and Stainless Steel)
  • Contained potent compound milling

Carbohydrate & Excipient Manufacturing

  • Bulk cGMP manufacturing scale:  Gram to Metric Ton
  • Class 100,000 drying facilities: isolated drying, milling, and packaging suites
  • Specialty carbohydrates and blocked sugars

R&D and Analytical

  • Research and development laboratories on-site
  • Analytical services lab:
    • Analytical method development and validation: 
      • Assay/release specification development for streamlined multi-compendial release
      • Impurity profiling
      • Structural analysis
      • Endotoxin and Glucan detection method development and validation
      • Elemental impurities quantitation at low ppb levels
      • Nitrosamine concentration, and N-Nitroso-structural impurities, nitrite concentration
      • DNA/RNA/DNase/RNase detection and validation
      • Reference standard qualification
      • Cleaning method development and validation
    • ICH stability testing and protocol development
    • Impurity marker characterization
    • KYPP Program to track and trend analytical quality attributes

Warehousing

  • Temperature and humidity controlled GMP finished product warehouse

Facility Support

  • Dedicated biological wastewater treatment facility
  • 24-hour maintenance/engineering support staff

What can we help you find?